Brief: Galapagos Receives Transparency Notification From Ecor1 Capital
16/09/2024 21:23
Sept 16 (Reuters) - Galapagos NV GLPG.AS :
* GALAPAGOS RECEIVES TRANSPARENCY NOTIFICATION FROM ECOR1
CAPITAL
Source text for Eikon: ID:nGNX1Q9lfM
Further company coverage: GLPG.AS
(Reuters.Briefs@thomsonreuters.com)
Recent news on Lakefront Biotherapeutics NV
See all newsBrief: Lakefront Announces Sale Of Preclinical Car-T Programs To Armed Cell Therapeutics
RBC upgrades Lakefront Biotherapeutics to 'outperform' on gamgertamig prospect
Brief: U.S. FDA Grants Orphan Drug Designation To Gamgertamig For The Treatment Of Pemphigus
Brief: Lakefront Biotherapeutics H1 Net Profit From Continuing Operations €15.8 Mln
Brief: Gilead Sciences and Lakefront Complete Acquisition of Ouro Medicines to Further Expand Inflammation Pipeline